Elisabeth Björk is a former Senior Vice President at AstraZeneca R&D, with over 20 years of experience in the biotechnology sector and approximately 15 years in clinical practice and academia. Currently, Elisabeth serves on several boards, including Rocket Pharmaceutical Inc., Pharvaris N.V., and Vicore Pharma AB, while also holding an independent director position at Chalmers University of Technology. Elisabeth has led significant drug development initiatives, notably in the cardiovascular and metabolic fields, advancing innovative science into patient-centered medicines. Based in Sweden, Elisabeth remains dedicated to advancing healthcare through their board involvement and research advisory roles.
This person is not in the org chart
This person is not in any teams
This person is not in any offices